Institute for Clinical & Economic Review Report Evaluates Effectiveness and Value of Brensocatib for Non-Cystic Fibrosis Bronchiectasis
2025-11-05
TNS-ReportsNonGov2025-11-05
Targeted News Service
WASHINGTON, Nov. 5 (TNSLrpt) -- The Institute for Clinical and Economic Review, Boston, Massachusetts, issued a report evaluating brensocatib, an oral inhibitor of dipeptidyl peptidase 1, for the trea . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 5 (TNSLrpt) -- The Institute for Clinical and Economic Review, Boston, Massachusetts, issued a report evaluating brensocatib, an oral inhibitor of dipeptidyl peptidase 1, for the trea . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025